These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6787418)

  • 1. ICR-191 and ethyl methanesulfonate induced mutagenesis at the immunoglobulin locus in the Y5606 cultured myeloma cell line.
    Wims LA; Morrison SL
    Mutat Res; 1981 Apr; 81(2):215-28. PubMed ID: 6787418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative and molecular analyses of ethyl methanesulfonate- and ICR 191-induced mutation in AS52 cells.
    Stankowski LF; Tindall KR; Hsie AW
    Mutat Res; 1986 Apr; 160(2):133-47. PubMed ID: 3512985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative forward-mutation specificity of mono-functional alkylating agents, ICR-191, and aflatoxin B1 in mouse lymphoma cells.
    MacInnes MA; Friedrich U; van Daalen Wetters T; Coffino P
    Mutat Res; 1982 Aug; 95(2-3):297-311. PubMed ID: 6289092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heavy chain-producing variants of a mouse myeloma cell line.
    Morrison SL; Scharff MD
    J Immunol; 1975 Feb; 114(2 Pt 1):655-9. PubMed ID: 804509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heritable alterations at the adenine phosphoribosyltransferase (APRT) locus in human lymphoblastoid cell lines.
    Amundson SA; Fortunato JE; Liber HL
    Mutat Res; 1992 Dec; 284(2):287-95. PubMed ID: 1281280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heavy-chain mutants derived from gamma 2b mouse myeloma: characterization of heavy-chain messenger ribonucleic acid, proteins, and secretion in delection mutants and messenger ribonucleic acid in gamma2a mutant progeny.
    Monk RJ; Morrison SL; Milcarek C
    Biochemistry; 1981 Apr; 20(8):2330-9. PubMed ID: 6263311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants of mouse myeloma cells that produce short immunoglobulin heavy chains.
    Birshtein BK; Preud'homme JL; Scharff MD
    Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3478-82. PubMed ID: 4139712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants of a mouse myeloma cell line that synthesize immunoglobulin heavy chains having an altered serotype.
    Preud'Homme JL; Birshtein BK; Scharff MD
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1427-30. PubMed ID: 805428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in immunoglobulin-producing mouse myeloma cells.
    Baumal R; Birshtein BK; Coffino P; Scharff MD
    Science; 1973 Oct; 182(4108):164-6. PubMed ID: 4354174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of immunoglobulin by substrate attached mouse myeloma cells.
    Bargellesi A; Damiani G; Kuehl WM; Scharff MD
    J Cell Physiol; 1976 Jun; 88(2):247-51. PubMed ID: 818094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between metabolic deactivation of ICR compounds and their differential mutagenicity in bacteria and cultured mammalian cells.
    De Flora S; Basso C; Camoirano A; Astengo M; Badolati GS
    Mutat Res; 1986 Jul; 174(3):227-32. PubMed ID: 2425256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in mouse myeloma cells: implications for human multiple myeloma and the production of immunoglobulins.
    Weitzman S; Margulies DH; Scharff MD
    Ann Intern Med; 1976 Jul; 85(1):110-6. PubMed ID: 820230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent synthesis of light and heavy chains: quantitation of light-chain production by mouse myeloma variants.
    Laskov R; Scharff MD
    J Exp Med; 1974 Oct; 140(4):1112-6. PubMed ID: 4139223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin biosynthesis by the MOPC 173 mouse myeloma tumor and a variant spleen clone.
    Baumal R; Scharff MD
    J Immunol; 1976 Jan; 116(1):65-74. PubMed ID: 812916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of a variant of mouse plasmacytoma J558 synthesizing a 110,000-dalton immunoglobulin heavy chain and of secondary variants synthesizing either a 55,000-dalton or an 80,000-dalton immunoglobulin heavy chain: possible implications.
    Matsuuchi L; Morrison SL
    Mol Cell Biol; 1982 Sep; 2(9):1134-44. PubMed ID: 6184610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of mutagens to increase rate of immunoglobulin isotype switching of hybridoma cells.
    Paizi M; Zivion D; Spira G
    Hybridoma; 1995 Feb; 14(1):85-90. PubMed ID: 7768537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis but not secretion of J chain by variant mouse myeloma cells which lose alpha-chain-synthesizing ability.
    Mosmann T; Baumal R
    J Immunol; 1975 Oct; 115(4):955-62. PubMed ID: 809509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo growth advantage of the MOPC-315 mouse myeloma over its immunoselected variants.
    Hannestad K; Kao MS; Lynch RG; Eisen HN
    J Natl Cancer Inst; 1977 Oct; 59(4):1307-10. PubMed ID: 409851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of immunoglobulin class-switch and variable-region variants from mouse myeloma and hybridoma cell lines.
    Radbruch A; Brüggemann M; Liesegang B; Rajewsky K
    Adv Exp Med Biol; 1982; 158():93-105. PubMed ID: 6818850
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolation and characterization of bleomycin-sensitive Chinese hamster ovary cells.
    Stamato TD; Peters B; Patil P; Denko N; Weinstein R; Giaccia A
    Cancer Res; 1987 Mar; 47(6):1588-92. PubMed ID: 2434221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.